Ilan Volovitz

600 citations

24 papers · 470 indexed · h-index 13

Impact in

Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 17
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 5
Genetics 6
- Mesenchymal stem cell research 3
- Glioma Diagnosis and Treatment 3

Co-authors: Lea Eisenbach Arthur Machlenkin Ofir Goldberger Esther Tzehoval Ezra Vadai Adrian Paz Boaz Tirosh Sung‐Hyung Lee
Journals: Neuro-Oncology (4 papers)Cell Death and Disease (2 papers)The Journal of Immunology (2 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)
Partner nations: Israel Germany United States

In The Last Decade

Ilan Volovitz

24 papers receiving 458 citations

Peers

Countries citing papers authored by Ilan Volovitz

Since Specialization

Citations

This map shows the geographic impact of Ilan Volovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Volovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Volovitz more than expected).

Fields of papers citing papers by Ilan Volovitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilan Volovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Volovitz. The network helps show where Ilan Volovitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Ilan Volovitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ilan Volovitz Line = papers co-authored together Ilan Volovitz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Highly Sensitive Flow Cytometric Approach to Detect Rare Antigen-Specific T Cells: Development and Comparison to Standard Monitoring Tools Cancers ·W Rapesak, Baruch Brenner, Michal Yalon, Zohar Levi, Zvi Livneh, Rozmie Razif Othaman, Tamar Paz-Elizur, Rachel Grossman, Zvi Ram, Ilan Volovitz	2023	2
2	Frequencies of 4 tumor-infiltrating lymphocytes potently predict survival in glioblastoma, an immune desert Neuro-Oncology ·Michael C. Danielski, Ali Sayah, I. A. Sherstnev, Tregeagle, Krongkaew Thongruangsooksai, 孝夫酒井, Ming Gao, Michaela del Campo, I. Giegling, J C Marchal, Gol'tsev Vd, Martin Tichý, A Altschul, Tal Shahar, Rachel Grossman, Zvi Ram, Ilan Volovitz	2023	11
3	CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis Journal of Neuroimmunology ·Lior Fuchs, Karin Mausner-Fainberg, 和田勝男, Susanna Asseyer, Maya Golan, D Xie, Ilan Volovitz, Keren Regev, Е. Н. Кузнецова, 嘉久山浦, Hadar Kolb, Friedemann Paul, Arnon Karni	2022	4
4	Rh2-enriched Korean ginseng (Ginseng Rh2+) inhibits tumor growth and development of metastasis of non-small cell lung cancer Food & Function ·Shahar Lev‐Ari, Gowtham Satya Kumar Kaja, Akiva Vexler, Lital Kalich‐Philosoph, Hwa‐Seung Yoo, Ki-Rok Kwon, Tomohiro Kuratani, Zhan-Peng Cui Zhan-Peng Cui, Amir Bar‐Shai, Ilan Volovitz, Yehuda Schwarz	2021	14
5	P12.05 Evaluating the compatibility of tumor treating electric fields with key antitumoral immune functions Neuro-Oncology ·J C Marchal, Tsung-Yu Wu, Tomás Murillo y Velarde, Anat Globerson Levin, Hou Cao, Zelig Eshhar, Niv Pencovich, Rachel Grossman, Zvi Ram, Ilan Volovitz	2019	1
6	Cryopreservation of Stromal Vascular Fraction Cells Reduces Their Counts but Not Their Stem Cell Potency Plastic & Reconstructive Surgery Global Open ·肇笹井, W. Christoph, Lemuel Herrera, Sadık Yiğit, Alla Yasinska, Ilan Volovitz, Meirav Sela, Amir Inbal, Eyal Gur, П. А. Трачук	2019	7
7	Fas-L promotes the stem cell potency of adipose-derived mesenchymal cells Cell Death and Disease ·肇笹井, Sadık Yiğit, Ilan Volovitz, Meirav Sela, Alla Yasinska, Shai Yarkoni, Dov Zipori, Eyal Gur, П. А. Трачук	2018	11
8	Identification of subsets of tumor infiltrating lymphocytes in primary brain tumors using multi-color panel flow cytometry Annals of Oncology ·Krongkaew Thongruangsooksai, Cm Ni, J R Raines, J C Marchal, Gol'tsev Vd, Zvi Ram, Ilan Volovitz	2017	1
9	A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells BMC Neuroscience ·Ilan Volovitz, Kamila Tomczyk, Emmanuel Ngoma, Matthew P Grandstaff, Olivier Guyot, Varoquaux Gaël, Krongkaew Thongruangsooksai, Ori Barzilai, Tal Shahar, Andrew A. Kanner, Itzhak Fried, Igor Veshchev, Rachel Grossman, Zvi Ram	2016	41
10	Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools International Reviews of Immunology ·Ilan Volovitz, Susanne Melzer, S. A. Gladyrevskaya, József Bocsi, Derek R. Charles, Sol Efroni, Zvi Ram, Attila Tárnok	2016	14
11	NOX1-induced accumulation of reactive oxygen species in abdominal fat-derived mesenchymal stromal cells impinges on long-term proliferation Cell Death and Disease ·Meirav Sela, J. Candal Alonso, Orly Ravid, Ilan Volovitz, 肇笹井, Or Friedman, Dov Zipori, Eyal Gur, Yakov Krelin, П. А. Трачук	2015	22
12	ImMucin: A novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors Vaccine ·Riva Kovjazin, Ilan Volovitz, Yulia Kundel, Eli Rosenbaum, Aybala ÇAYIR, Galit Horn, Nechama I. Smorodinsky, Baruch Brenner, Lior Carmon	2011	34
13	Split Immunity: Immune Inhibition of Rat Gliomas by Subcutaneous Exposure to Unmodified Live Tumor Cells The Journal of Immunology ·Ilan Volovitz, Anja Puggaard, Fajar Khiyat Santoso, Arthur Machlenkin, Ofir Goldberger, Felix Mor, Shimon Slavin, Zvi Ram, Irun R. Cohen, Lea Eisenbach	2011	16
14	Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: Implications for vaccine development Molecular Immunology ·Riva Kovjazin, Ilan Volovitz, Engelken, Dr Komarasamy G, W. Wang, Lu Mengting, Lior Carmon, Yoram Louzoun	2011	40
15	T cell vaccination induces the elimination of EAE effector T cells: Analysis using GFP-transduced, encephalitogenic T cells Journal of Autoimmunity ·Ilan Volovitz, Anja Puggaard, Felix Mor, Alexander Flügel, Francesca Odoardi, Lea Eisenbach, Irun R. Cohen	2010	10
16	T‐cell seeding: neonatal transfer of anti‐myelin basic protein T‐cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis Immunology ·Ilan Volovitz, Felix Mor, Haoxin Chen, Ofir Goldberger, Anja Puggaard, Lea Eisenbach, Irun R. Cohen	2009	3
17	Exuberated Numbers of Tumor-Specific T Cells Result in Tumor Escape Cancer Research ·Ofir Goldberger, Ilan Volovitz, Arthur Machlenkin, Ezra Vadai, Esther Tzehoval, Lea Eisenbach	2008	28
18	Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice Cancer Immunology Immunotherapy ·Arthur Machlenkin, Ronit Rosenfeld, Ilan Volovitz, Ezra Vadai, Avital Lev, Adrian Paz, Ofir Goldberger, Yoram Reiter, Esther Tzehoval, Itai Benhar, Lea Eisenbach	2006	16
19	Human CTL Epitopes Prostatic Acid Phosphatase-3 and Six-Transmembrane Epithelial Antigen of Prostate-3 as Candidates for Prostate Cancer Immunotherapy Cancer Research ·Arthur Machlenkin, Adrian Paz, Yulia Vladimirovna Erkeeva, Ofir Goldberger, Atojonova Muharram Sharofiddin qizi, Boaz Tirosh, Ilan Volovitz, Ezra Vadai, Gilles Lugassy, Shmuel Cytron, François A. Lemonnier, Esther Tzehoval, Lea Eisenbach	2005	64
20	In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL Cancer Gene Therapy ·Sung‐Hyung Lee, Erez Bar‐Haim, Arthur Machlenkin, Ofir Goldberger, Ilan Volovitz, Ezra Vadai, Esther Tzehoval, Lea Eisenbach	2004	19

About Ilan Volovitz

Ilan Volovitz is a scholar working on Immunology, Genetics, Oncology, Neurology and Molecular Biology, having authored 24 papers that have together received 470 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers), Mesenchymal stem cell research (3 papers), CAR-T cell therapy research (3 papers), Glioma Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and vaccines and immunoinformatics approaches (3 papers). The work is most often cited by research in Immunology (263 citations), Oncology (173 citations), Genetics (48 citations), Molecular Biology (191 citations) and Biotechnology (22 citations). Ilan Volovitz has collaborated with scholars based in Israel, Germany and United States. Frequent co-authors include Lea Eisenbach, Arthur Machlenkin, Ofir Goldberger, Esther Tzehoval, Ezra Vadai, Adrian Paz, Boaz Tirosh, Sung‐Hyung Lee, Erez Bar‐Haim and Riva Kovjazin. Their work appears in journals such as Neuro-Oncology, Cell Death and Disease, The Journal of Immunology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact